Site Content
Products
Quote
Order Online
Catalog Class I Pentamers
Custom Class I Pentamers
Catalog Class I Monomers
Custom Class I Monomers
Matched Peptides
Fluorotag & Biotag
Custom Peptide Synthesis
Antibodies
Streptavidin - Fluorochrome
CD1d Tetramers
MR1 Tetramers
Catalog Class II Monomers
Custom Class II Monomers
ProMix
TM
Peptide Pools
Catalog Class II Tetramers
Custom Class II Tetramers
Login
Products
Ankyrons
™
Introduction to Ankyrons
Catalog Ankyrons
Custom Ankyrons
Pro5
®
MHC Class I Pentamers
Introduction to Pentamers
Catalog Pentamers
Custom Pentamers
HLA-E Pentamers
Biotin Labeled Pentamers
Simian Pentamers
Chimeric A2Kb Pentamers
ProVE
®
Pentamer Libraries
ProM1® MHC Class I Monomers
ProT2
®
MHC Class II Tetramers
Introduction to ProT2
®
MHC Class II Tetramers
List of Catalog ProT2
®
MHC Class II Tetramers
ProM2
®
MHC Class II Monomers
Introduction to ProM2
®
MHC Class II Monomers
List of Catalog ProM2
®
MHC Class II Monomers
CD1d Tetramers
MR1 Tetramers
thinkpeptides
®
Peptide Products
Custom Peptide Synthesis
ProMix™ Peptide Pools
Antibodies
Services
ProPresent
®
Antigen Presentation Assay
ProMap
®
T Cell Proliferation Assays
ProScern
®
DC-T Cell Proliferation Assays
Mixed Lymphocyte Reaction (MLR) Assays
ProImmune REVEAL & ProVE
®
ProImmune REVEAL & ProVE
®
Overview
MHC Class I Binding Assays
MHC Class II Binding Assays
Mouse Class II Binding Assays
HLA Class II Competition Assay
ProStorm
®
Cytokine Release Assay
MutaMap
®
Mutational Activity Map
ProSpot
®
T cell ELISpot Assays
ProSpot
®
B Cell ELISpot Assays
B Cell Linear Epitope Mapping
Immunocytometry Assay Service
Blood Processing Service
typeHLA: HLA Typing Service
Special Assay Service
Immunogenicity Services
Immunogenicity of Biotherapeutics
Immunogenicity Risk of Complex Peptide Products
Immunotoxicology Testing
Resources
Download Pro5® Pentamer Handbook
Ankyron Protocols
Multimer Protocols and others
Customer Research Case Studies
Selected Customer Publications
Customer Testimonials
MHC Allele Frequencies
Price Lists
Request Information
Quote for Products or Services
Frequently Asked Questions
News
Support
Multimer Flow Cytometry
Custom Peptides
Custom Peptide Libraries
Ankyron Protocols
Multimer Protocols and other
Pro5
®
Pentamer Applications
Flow Cytometry
Magnetic Bead Cell Separation
Tissue Staining
Custom Peptide Applications
Peptide Applications Support
Intracellular Cytokine Staining
About
About ProImmune
Our Clients
Quality
Terms of Business
Privacy Policy
Careers
Current Opportunities
Careers at ProImmune
Graduate Recruitment
Recruitment Process
Company Culture
Benefits
Frequently Asked Questions
Contact Us
Contact Us
Distributors
中文
Home
×
Allergy
Katharina Steinitz,
Baxter, Austria
What causes adverse reactions to Factor VIII treatment?
Julio Delgado,
University of Utah
The Who How and Why of Seafood Allergy, using ProImmune’s Antigen Characterization Platform
T cell Assays for Allergenicity Testing: How do Functionally Similar Proteins Compare in their Immunogenicity?
Autoimmunity
Dolores Jaraquemada,
Universitat Autònoma de Barcelona
Grave’s Disease Peptides are Characterized using ProImmune Class II REVEAL Binding Assay
Philippe Blancou,
INSERM
Identification of New Epitopes in Type 1 Diabetes
Lena Israelsson,
Karolinska Institute
Defining Autoantibody Binding to Citrullinated Target Proteins in Rheumatoid Arthritis using Peptide Arrays
Kaare Engkilde,
University of Copenhagen
Mouse CD1d Tetramers Used to Correlate NKT Cell Activity with Protection from Type 1 Diabetes
Damien Bresson,
LIAI
Research Into Type I Diabetes Therapy Makes use of PEPscreen® Technology
Terrance O'Hanlon,
National Institute of Environmental Health Sciences
Invited Editorial: Epitope Discovery for Inflammatory Myopathy Treatment
More Autoimmunity Publications Citing ProImmune
Cancer
Immunovaccine Inc, Nova Scotia, Canada
Liposomes deliver an immune hit to cancer cells
Marcus Butler,
Dana Farber Cancer Centre
Killer T Cells Trained for Long-lasting Anti-Cancer Effects
John Webb,
British Columbia Cancer Agency
High-grade Ovarian Cancer: MHC Pentamers are Used to Investigate Immunotherapy Prospects
Ingerid Abrahamsen,
Oslo University Hospital, Oslo
Allogeneic T Cells May Be Targeted to B Cell Leukemia
Erlend Stronen,
Radiumhospitalet Oslo
Pentamers Identify Allo-restricted T Cells in Study to Advance Research Into Cancer Immunotherapy
Richard Harrop,
Oxford Biomedica
Novel Epitope Detection in Phase II Trial for Colorectal Cancer
Maxim Pavlenko,
Karolinska University Hospital
Epitope Discovery in Prostate Cancer: Characterizing an Immunodominant CTL Epitope of PSA in Mice
Vincenzo Cerullo,
University of Helsinki
First Ever Tumor-specific Response Observed for Human Patients in Oncolytic Adenovirus Cancer Gene Therapy Study
James Wells,
King’s College London
New Adjuvant Drives Unprecedented Cytotoxic T Cell Response Providing a Potent Vaccine Development Platform
Hiro Yagi,
Hamamatsu University School of Medicine
Pro5® Pentamers Integral in Successful Research Into Novel Immunization Strategy
Norman Woller, Edkulla Ramakrishna,
Medizinische Hochschule Hannover
Using thinkpeptides to Improve Virotherapy Against Tumor Targets
More Cancer Publications Citing ProImmune
CMV
Claire Ventura,
Sanofi Pasteur, France
Finding a way to control chronic CMV infection
Daniela Weiskopf,
Austrian Academy of Sciences
ProImmune REVEAL® Rate assays and Pro5® Pentamers Central to Study Investigating Oxidative Stress
Paul Moss,
University of Birmingham
Pro5® Pentamers are Used to Enrich CMV-specific T Cells for Transfusion Into Transplant Patients
More CMV Publications Citing ProImmune
EBV
Stephanie Gras,
Queensland Institute of Medical Research
Analyzing Allelic Polymorphism in the T Cell Receptor and its Impact on Immune Responses in an EBV Setting
Judy Tellam,
Queensland Institute of Medical Research
Pro5® MHC Class I Pentamer Combined with Intracellular Cytokine Staining Shows How Protein Translation Affects the Molecular Dynamics of Antigen Presentation
Christopher Fox,
University of Birmingham
Researchers Use Pro5® MHC Pentamers to Identify an Exciting New Target for EBV Treatment
Michael Uhlin,
Karolinska Institute
Pro5® Pentamers Central in Life-saving Procedure for PTLD Treatment
Michael Uhlin,
Karolinska Institute
Invited Editorial: The Best Strategy for Adoptive T Cell Transfer
Suzanne Elliot,
Queensland Institute of Medical Research
Pro5® MHC Class I Pentamers Used to Evaluate Vaccine Safety
John J. Miles,
Cardiff University School of Medicine
Invited Editorial: Tracking the TCR Repertoire Evolution During Primary Viral Infection in Humans
More EBV publications citing ProImmune
Haemophilia
Gouri Pandey,
FDA
ProImmune REVEAL® Class II HLA-Peptide Binding Assay used to identify potential potential FVIII epitopes that increase the risk of FVIII inhibitors in African-American Haemophilia A patients compared with Caucasians
Katherine High,
The Children’s Hospital of Philadelphia
Pro5® MHC Pentamers used in conjunction with ProPresent® Antigen Presentation Assays to identify MHC class I epitopes in AAV vectors that trigger cytotoxic T cell responses when presented by hepatocytes
Hepatitis (HBV and HCV)
Adam Gehring,
Singapore Institute for Clinical Science
Phenotypic Analysis of HBV-specific T Cells Using Pro5® Pentamers
Victoria Kasprowicz,
University of KwaZulu Natal
A Story of Viral Escape Through Sequence Variation in Chronic Hepatitis C Virus Infection
Lars Frelin,
Karolinska Institute
Developing a Therapeutic Hepatitis B Vaccine with Pro5® Pentamers
Eleanor Barnes,
University of Oxford
Success for Hepatitis C Vaccine Trials at Oxford University
Tanja Lange,
University of Lübeck
Sleep Your Way to Better Immunity – Sleep After Vaccination Boosts Immunological Memory
More Hepatitis Publications Citing ProImmune
HIV
Samantha Westrop,
Chelsea & Westminster Hospital
ProImmune REVEAL & ProVE® Rapid Epitope Discovery System used to Identify Novel T Cell Epitopes in HIV-1
Jorge Almeida,
INSERM
T Cell Vaccines for HIV-1 Move a Step Closer – Researchers Use HIV-specific Pro5® MHC Class I Pentamers Combined with Intracellular Cytokine Staining
Aude Chapuis,
Fred Hutchinson Cancer Research Center, USA
Sending in Trained Killers to Attack Residual HIV Infection
University of Manitoba Researchers Use PEPscreen® Library for Epitope Mapping
Tarmo Mölder,
University of Tartu
HIV Vaccine Study in Pigs Uses PEPscreen® Peptides in ELISpot Assays
More HIV Publications Citing ProImmune
Infectious Diseases
Paul Arnaboldi,
New York Medical Center
Diagnostic Peptide Epitope for Lyme Disease Identified with ProArray Ultra®
Sanja Selak,
Intercell AG
Developing Effective Vaccine Strategies for Complex Pathogens
Maziar Divangahi,
Harvard Medical School, USA
A Messy End for TB-infected Macrophages
Ana Ferreira,
Instituto Gulbekian de Ciência, Portugal
Researchers Show How Inheritance of Sickle Cell Anemia Protects Against Malaria Infection
Virginie Roupie,
Scientific Institute of Public Health, Brussels
PEPscreen® Used in Vaccine Development for Mycobacterium Tuberculosis
Cyrille Bisseye,
Medical Research Council UK and The Gambia
Designing a Malaria Vaccine
Infectious Diseases
Infectious Diseases
Paul Arnaboldi,
New York Medical Center
Diagnostic Peptide Epitope for Lyme Disease Identified with ProArray Ultra®
Sanja Selak,
Intercell AG
Developing Effective Vaccine Strategies for Complex Pathogens
Maziar Divangahi,
Harvard Medical School, USA
A Messy End for TB-infected Macrophages
Ana Ferreira,
Instituto Gulbekian de Ciência, Portugal
Researchers Show How Inheritance of Sickle Cell Anemia Protects Against Malaria Infection
Virginie Roupie,
Scientific Institute of Public Health, Brussels
PEPscreen® Used in Vaccine Development for Mycobacterium Tuberculosis
Cyrille Bisseye,
Medical Research Council UK and The Gambia
Designing a Malaria Vaccine
Influenza
J Guo,
University of Texas
Deletion of FoxN1 in the thymic medullary epithelium reduces peripheral T cell responses to infection and mimics changes of aging
Roberto Mallone,
Hôpital Saint Vincent de Paul
How Does Blood Processing Affect the Results of Cell Mediated Immunity Assays? ProImmune’s Flu Pro5® MHC Class I Pentamer is Used as an Exemplar in an Exploratory Study
Sohail Ahmed,
Novartis
ProImmune REVEAL® MHC Peptide Binding Assays used by team at Novartis and Stanford University to investigate immunological insights into the causation of narcolepsy associated with pandemic H1N1 influenza vaccine Pandemrix®
More Influenza Publications Citing ProImmune
NKT Cells and CD1d
Patricia Barral,
Cancer Research UK
ProImmune CD1d Tetramers Provide Novel Insights Into NKT Cell Activation
Stefan Porubsky,
DKFZ
The Significance of Isoglobotrihexosylceramide (iGb3) as the Natural CD1d Ligand in Mice
Maya Fedeli,
H San Raffaele Scientific Institute
NKT Cell Differentiation Depends on Dicer Processing of MicroRNA
Thierry Mallevaey,
INSERM
NKT Cells are Important in the Acquired Immune Response During Helminthiasis
Omar Duramad,
Regimmune
ProImmune’s Human CD1d Tetramer Detects NKT Cells from Non-human Primates
More Publications Citing ProImmune CD1d Tetramers
Other Viral diseases
Defence Science and Technology Laboratories, UK
The Human Side of Counter-Bioterrorism: T Cell Proliferation Assays Validate Humanization of an anti-VEEV Antibody
Gene Olinger, USAMRIID
ProImmune’s Antigen Characterization Platform Accelerates Development of a Vaccine for Ebola and Marburg Viruses
Giovanna Rappocciolo,
University of Pittsburgh
ProImmune’s REVEAL & ProVE® Rapid Epitope Discovery System Validates Novel Epitopes Important for CD8+ T Cell Control of Human Herpesvirus 8
Andre Oliveira,
University College Dublin
ProImmune REVEAL and ProVE® Used to Identify First HTLV-2 MHC Class I Epitope
Pim van der Heiden,
Leiden University Medical Center
Discovery of First VZV HLA-A2 Epitope, Using ProImmune REVEAL & ProVE® Technology
Transplantation
Transplantation
Bruce Blazar,
University of Minnesota
In Situ Identification of Allospecific B Cells using Pentamers
